Comparison of serum, cerebrospinal fluid and brain extracellular fluid pharmacokinetics of lamotrigine.
about
Efficacy of antiepileptic isomers of valproic acid and valpromide in a rat model of neuropathic painA microdialysis study of the novel antiepileptic drug levetiracetam: extracellular pharmacokinetics and effect on taurine in rat brainEffect of lamotrigine and carbamazepine on corticotropin-releasing factor-associated serotonergic transmission in rat dorsal raphe nucleusDrug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery.Protein-functionalized PLGA nanoparticles of lamotrigine for neuropathic pain management.Neonatal exposure to antiepileptic drugs disrupts striatal synaptic developmentToward the prediction of CNS drug-effect profiles in physiological and pathological conditions using microdialysis and mechanism-based pharmacokinetic-pharmacodynamic modeling.The pharmacokinetics of antiepileptic drugs in rats: consequences for maintaining effective drug levels during prolonged drug administration in rat models of epilepsy.Neuroprotection of lamotrigine on hypoxic-ischemic brain damage in neonatal rats: Relations to administration time and doses.Prediction of antiepileptic drug efficacy: the use of intracerebral microdialysis to monitor biophase concentrations.Methodologies used to identify and characterize interactions among antiepileptic drugs.Utility of CSF in translational neuroscience.Comparison of brain extracellular fluid, brain tissue, cerebrospinal fluid, and serum concentrations of antiepileptic drugs measured intraoperatively in patients with intractable epilepsy.Modulatory effects of neuropsychopharmaca on intracellular pH of hippocampal neurones in vitro.The pharmacokinetics of letrozole in brain and brain tumor in rats with orthotopically implanted C6 glioma, assessed using intracerebral microdialysis.Lamotrigine inhibits postsynaptic AMPA receptor and glutamate release in the dentate gyrus.Lamotrigine pharmacokinetic/pharmacodynamic modelling in rats.Permeability of blood-brain barrier in macaque model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson disease.
P2860
Q24670430-D2C47FA5-93E4-4626-BD57-8200D59EF4E9Q28343920-2B7E0EFC-373C-4F28-B7F3-E3A1AB0B3B8FQ28564629-D6A7CBB8-6833-49A8-BBAF-BECC27F58E3EQ33946973-7A901332-14AA-4555-A856-4C1153A51383Q35209969-33F4064B-A443-47E8-89D0-BE08405C2733Q36170106-E27CB720-3135-4983-BC96-15FC441106E8Q36341660-0FE1F7BF-F2D7-4D29-AE8E-D1861594DF7BQ36794851-9EC2E7E5-7815-4C43-98AF-A21099D1D528Q37290670-BE304DEA-6F40-4C41-BC76-2131FE652F08Q37554396-5179DCF6-237D-41F6-907F-80862F44AE32Q38018676-E0420093-DD2E-4A45-9F5B-E9662DFD01FBQ38080762-A39B4A7D-7A94-4A2E-B024-1FBBA30716FFQ40329175-AEDD9965-78A2-400A-B710-D64F5B7D02B2Q42040758-CDE281F4-25B8-49EF-A37E-AEB5DA71B4BBQ43565983-80355987-C45A-4BA9-A79B-A0DD2D89DC30Q46773153-2AEED3DB-5698-48A0-AA7F-3A2D3D822230Q46824200-82FA993A-B814-47EC-95E0-E3334119ACBEQ48956010-EB85BF71-BD6B-4D7D-A95B-2D314EFEA758
P2860
Comparison of serum, cerebrospinal fluid and brain extracellular fluid pharmacokinetics of lamotrigine.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Comparison of serum, cerebrosp ...... armacokinetics of lamotrigine.
@en
Comparison of serum, cerebrosp ...... armacokinetics of lamotrigine.
@nl
type
label
Comparison of serum, cerebrosp ...... armacokinetics of lamotrigine.
@en
Comparison of serum, cerebrosp ...... armacokinetics of lamotrigine.
@nl
prefLabel
Comparison of serum, cerebrosp ...... armacokinetics of lamotrigine.
@en
Comparison of serum, cerebrosp ...... armacokinetics of lamotrigine.
@nl
P2093
P2860
P356
P1476
Comparison of serum, cerebrosp ...... armacokinetics of lamotrigine.
@en
P2093
P2860
P304
P356
10.1038/SJ.BJP.0703337
P407
P577
2000-05-01T00:00:00Z